title: Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
authors: Nicolas
authors: N
authors: Boissel
authors: Olivier
authors: O
authors: Nibourel
authors: Aline
authors: A
authors: Renneville
authors: Pascal
authors: P
authors: Huchette
authors: Hervé
authors: H
authors: Dombret
authors: Claude
authors: C
authors: Preudhomme
mesh_terms: D002986:Clinical Trials as Topic; D020732:Cytogenetic Analysis; D003937:Diagnosis, Differential; D005820:Genetic Testing; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D009154:Mutation / Q000502:physiology; D011379:Prognosis; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: C538784:IDH2 protein, human; D007521:Isocitrate Dehydrogenase